What are the main segments within the overall human vaccines market? How much will each of these segments be worth for the period 2015 to 2025?

Other emerging players are making novel technology-based vaccines which are likely to affect the market share during the forecast period. The emerging players are evaluated on various parameters such as business overview, promising vaccines in the clinical development with phase, platform technology and diseases which are seeing vaccines development activity such as infectious diseases, non-infectious diseases, emerging pathogens, and recent development.

The report concludes with the profiles of the key players in the global human vaccines market. The key players are evaluated on various parameters such as business overview, vaccines portfolio, promising vaccines in the clinical development, vaccines revenue analysis and recent development.

Key trends in terms of collaboration, partnerships, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also examines the main market growth driving and restraining forces and also gives an all-round future outlook through 2025.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides in-depth analysis, information and revenue according to segments such as disease indications, end-users, leading vaccines, and companies from 2015 to 2018 and forecasts to 2025. A comprehensive analysis has been done on market share with percentage of all the segments.

Highlighted with 35 tables and 140 figures, this 310-page report “Global Human Vaccines Market Size, Trends, Opportunities and Growth Potential” provides a comprehensive analysis of the fast-evolving, high-growth global human vaccines market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the global human vaccines market. The report provides historical market data for 2015 – 2018, and forecasts from 2019 till 2025.

Table of Contents

1. Executive Summary

2. Global Vaccines Market Size & Forecast (2015 – 2025)

3. Market Share Analysis of Global Vaccines Market (%)

3.1 Global Vaccines Market Share, By Disease

3.2 Global Vaccines Market Share, By End User

3.3 Global Vaccines Market Share, By Leading Vaccine

3.4 Global Vaccines Market Share, By Company

4. Global Vaccines Market – Key Market Dynamics

4.1 Key Market Drivers

4.2 Key Market Inhibitors

5. Global Vaccines Market, By Disease

5.1 Pneumococcal Disease

5.2 Diphtheria, Tetanus and Pertussis (DTP)

5.3 Influenza

5.4 Human Papilloma Virus (HPV)

5.5 Meningococcal

5.6 Hepatitis

5.7 Measles, Mumps, and Rubella (MMR)

5.8 Rotavirus

5.9 Varicella

5.10 Other Diseases

6. Global Vaccines Market, By End User

6.1 Pediatric Vaccines

6.2 Adult Vaccines

7. Global Vaccines Market, By Leading Vaccine

7.1 Prevnar / Prevnar 13

7.2 Gardasil / Gardasil 9

7.3 Vaxigrip

7.4 Fluzone

7.5 Flublok

7.6 Varivax

7.7 Menactra

7.8 Proquad

7.9 Pneumovax 23

7.10 Fluarix/FluLaval

7.11 Havrix/Twinrix/Engerix–B

7.12 Priorix, Priorix Tetra, Varilrix

7.13 M–M–R II

7.14 Adacel

7.15 Boostrix

7.16 Bexsero

7.17 Menveo

7.18 Cervarix

7.19 Trumenba

7.20 Shingrix

7.21 Pentacel, Pentaxim, Imovax, Hexaxim

7.22 Rotateq

7.23 Zostavax

7.24 Rotarix

7.25 Synflorix

7.26 Pediarix,Infanrix

7.27 Ticovac

7.28 Biken Ha

7.29 Tetrabik

7.30 Mearubik

7.31 Varicella (MTP)

7.32 Jebik V

7.33 Flumist/Fluenz

7.34 BioThrax

7.35 Dukoral

7.36 Ixiaro

7.37 InLive

7.38 HeaLive

7.39 BiLive

7.40 Anflu

7.41 EasySix

7.42 Imvamune

7.43 Other Vaccines

8. Major Deals and Agreement Happenings in the Global Vaccines Market

8.1 Merger & Acquisitions

8.2 Collaboration Deal

8.3 Licensing Agreement

8.4 Exclusive Agreement

8.5 Distribution Agreement

8.6 Partnerships

9. Key Players in the Global Vaccines Market

9.1 Sanofi Pasteur

9.1.1 Business Overview

9.1.2 Vaccines Portfolio

9.1.3 Vaccines Market Value Analysis & Forecast

9.1.4 Promising Vaccines in the Clinical Development

9.1.5 Recent Development

9.2 GlaxoSmithKline (GSK)

9.2.1 Business Overview

9.2.2 Vaccines Portfolio

9.2.3 Vaccines Market Value Analysis & Forecast

9.2.4 Promising Vaccines in the Clinical Development

9.2.5 Recent Development

9.3 Merck

9.3.1 Business Overview

9.3.2 Vaccines Portfolio

9.3.3 Vaccines Market Value Analysis & Forecast

9.3.4 Promising Vaccines in the Clinical Development

9.3.5 Recent Development

9.4 Pfizer

9.4.1 Business Overview

9.4.2 Vaccines Portfolio

9.4.3 Vaccines Market Value Analysis & Forecast

9.4.4 Promising Vaccines in the Clinical Development

9.4.5 Recent Development

9.5 AstraZeneca

9.5.1 Business Overview

9.5.2 Vaccines Portfolio

9.5.3 Vaccines Market Value Analysis & Forecast

9.5.4 Recent Development

9.6 Mitsubishi Tanabe Pharma

9.6.1 Business Overview

9.6.2 Vaccines Portfolio

9.6.3 Vaccine Market Value Analysis & Forecast

9.6.4 Promising Vaccines in the Clinical Development

9.6.5 Recent Development

9.7 Emergent BioSolutions

9.7.1 Business Overview

9.7.2 Vaccines Portfolio

9.7.3 Vaccine Market Value Analysis & Forecast

9.7.4 Promising Vaccines in the Clinical Development

9.7.5 Recent Development

9.8 Astlellas Pharma Inc

9.8.1 Business Overview

9.8.2 Vaccines Portfolio

9.8.3 Vaccines Market Value Analysis & Forecast

9.8.4 Recent Development

9.9 Valneva

9.9.1 Business Overview

9.9.2 Vaccines Portfolio

9.9.3 Vaccines Market Value Analysis & Forecast

9.9.4 Promising Vaccines in the Clinical Development

9.9.5 Recent Development

9.10 Seqirus

9.10.1 Business Overview

9.10.2 Vaccines Portfolio

9.10.3 Vaccine Market Value Analysis & Forecast

9.10.4 Promising Vaccines in the Clinical Development

9.10.5 Recent Development

9.11 Bavarian Nordic

9.11.1 Business Overview

9.11.2 Vaccines Portfolio

9.11.3 Vaccine Market Value Analysis & Forecast

9.11.4 Promising Vaccines in the Clinical Development

9.11.5 Recent Development

9.12 Sinovac

9.12.1 Business Overview

9.12.2 Vaccines Portfolio

9.12.3 Vaccine Market Value Analysis & Forecast

9.12.4 Promising Vaccines in the Clinical Development

9.12.5 Recent Development

9.13 Panacea Biotec

9.13.1 Business Overview

9.13.2 Vaccines Portfolio

9.13.3 Vaccine Market Value Analysis & Forecast

9.13.4 Promising Vaccines in the Clinical Development

9.13.5 Recent Development

9.14 Bharat Biotech

9.14.1 Business Overview

9.14.2 Vaccines Portfolio

9.14.3 Promising Vaccines in the Clinical Development

9.14.4 Recent Development

9.15 Serum Institute of India

9.15.1 Business Overview

9.15.2 Vaccines Portfolio

9.15.3 Promising Vaccines in Clinical Development

9.15.4 Recent Development

9.16 Biological E. Limited

9.16.1 Business Overview

9.16.2 Vaccines Portfolio

9.16.3 Promising Vaccines in Clinical Development

9.16.4 Recent Development

10. Emerging Players in the Global Vaccines Market

10.1 Vaccitech

10.1.1 Business Overview

10.1.2 Promising Vaccines in the Clinical Development

10.1.3 Recent Development

10.2 Janssen (Johnson & Johnson)

10.2.1 Business Overview

10.2.2 Promising Vaccines in the Clinical Development

10.2.3 Recent Development

10.3 Novavax

10.3.1 Business Overview

10.3.2 Promising Vaccines in the Clinical Development

10.3.3 Recent Development

10.4 VBI Vaccines

10.4.1 Business Overview

10.4.2 Promising Vaccines in the Clinical Development

10.4.3 Recent Development

10.5 GeoVax

10.5.1 Business Overview

10.5.2 Promising Vaccines in the Clinical Development

10.5.3 Recent Development

10.6 Moderna Inc

10.6.1 Business Overview

10.6.2 Promising Vaccines in the Clinical Development

10.6.3 Recent Development

10.7 Biondvax

10.7.1 Business Overview

10.7.2 Promising Vaccines in the Clinical Development

10.7.3 Recent Development

10.8 Integrated Biotherapeutics Inc

10.8.1 Business Overview

10.8.2 Promising Vaccines in the Clinical Development

10.8.3 Recent Development

10.9 GeneOne Life Science

10.9.1 Business Overview

10.9.2 Promising Vaccines in the Clinical Development

10.9.3 Recent Development

10.10 Profectus BioSciences

10.10.1 Business Overview

10.10.2 Promising Vaccines in the Clinical Development

10.10.3 Recent Development

10.11 Pneumagen

10.11.1 Business Overview

10.11.2 Promising Vaccines in the Clinical Development

10.11.3 Recent Development

10.12 Themis Bioscience

10.12.1 Business Overview

10.12.2 Promising Vaccines in the Clinical Development

10.12.3 Recent Development

10.13 Xeme Biopharma Inc

10.13.1 Business Overview

10.13.2 Promising Vaccines in the Clinical Development

10.13.3 Recent Development

10.14 Altimmune

10.14.1 Business Overview

10.14.2 Promising Vaccines in the Clinical Development

10.14.3 Recent Development

10.15 Pfenex Inc

10.15.1 Business Overview

10.15.2 Promising Vaccines in the Clinical Development

10.15.3 Recent Development

10.16 Northwest Biotherapeutics

10.16.1 Business Overview

10.16.2 Promising Vaccines in the Clinical Development

10.16.3 Recent Development

10.17 OncBioMune Pharmaceuticals

10.17.1 Business Overview

10.17.2 Promising Vaccines in the Clinical Development

10.17.3 Recent Development

List of Tables:

Table 9–1: Merger & Acquisitions in the Global Vaccines Market

Table 9–2: Collaboration Deal in the Global Vaccines Market

Table 9–3: Licensing Agreement in the Global Vaccines Market

Table 9–4: Exclusive Agreement in the Global Vaccines Market

Table 9–5: Distribution Agreement in the Global Vaccines Market

Table 9–6: Partnerships in the Global Vaccines Market

Table 10–1: Sanofi Promising Vaccines in the Clinical Development

Table 10–2: GSK Promising Vaccines in the Clinical Development

Table 10–3: Merck Promising Vaccines in the Clinical Development

Table 10–4: Pfizer Promising Vaccines in the Clinical Development

Table 10–5: Mitsubishi Tanabe Pharma Promising Vaccines in the Clinical Development

Table 10–6: Emergent Biosolutions Promising Vaccines in the Clinical Development

Table 10–7: Valneva Promising Vaccines in the Clinical Development

Table 10–8: Seqirus Promising Vaccines in the Clinical Development

Table 10–9: Bavarian Nordic Promising Vaccines in the Clinical Development

Table 10–10: Sinovac Promising Vaccines in the Clinical Development

Table 10–11: Panacea Biotec Promising Vaccines in the Clinical Development

Table 10–12: Bharat Biotech Promising Vaccines in the Clinical Development

Table 11–1: Vaccitech Promising Vaccines in the Clinical Development

Table 11–2: Janssen Promising Vaccines in the Clinical Development

Table 11–3: Novavax Promising Vaccines in the Clinical Development

Table 11–4: VBI Vaccines Promising Vaccines in the Clinical Development

Table 11–5: GeoVax Promising Vaccines in the Clinical Development

Table 11–6: Moderna Promising Vaccines in the Clinical Development

Table 11–7: Biondvax Promising Vaccines in the Clinical Development

Table 11–8: Integrated Biotherapeutics Promising Vaccines in the Clinical Development

Table 11–9: GeneOne Life Science Promising Vaccines in the Clinical Development

Table 11–10: Profectus BioSciences Promising Vaccines in the Clinical Development

Table 11–11: Pneumagen Promising Vaccines in the Clinical Development

Table 11–12: Themis Bioscience Promising Vaccines in the Clinical Development

Table 11–13: Xeme Biopharma Promising Vaccines in the Clinical Development

Table 11–14: Altimmune Vaccines Promising Vaccines in the Clinical Development

Table 11–15: Pfenex Inc Promising Vaccines in the Clinical Development

Table 11–16: Northwest Biotherapeutics Promising Vaccines in the Clinical Development

Table 11–17: OncoBioMune Pharmaceuticals Promising Vaccines in the Clinical Development

List of Figures:

Figure 2–1: Global Vaccines Market Size (Million US$),2015 – 2018

Figure 2–2: Global Vaccines Market Size Forecast (Million US$),2019 – 2025

Figure 3–1: Global Vaccines Market Share, By Disease Indication (Percent),2018

Figure 3–2: Global Vaccines Market Share, By End User (Percent),2018

Figure 3–3: Global Vaccines Market Share by Brand (Percent), 2018

Figure 3–4: Global Vaccines Market Share by Company (Percent), 2018

Figure 5–1: Global Vaccines Market for Pneumococcal Disease (Million US$),2015 – 2018

Figure 5–2: Global Vaccines Market for Pneumococcal Disease Forecast (Million US$),2019 – 2025

Figure 5–3: Global Vaccines Market for DTP Disease (Million US$),2015 – 2018

Figure 5–4: Global Vaccines Market for DTP Disease Forecast (Million US$),2019 – 2025

Figure 5–5: Global Vaccines Market for Influenza Disease (Million US$),2015 – 2018

Figure 5–6: Global Vaccines Market for Influenza Disease Forecast (Million US$),2019 – 2025

Figure 5–7: Global Vaccines Market for HPV Disease (Million US$),2015 – 2018

Figure 5–8: Global Vaccines Market for HPV Disease Forecast (Million US$),2019 – 2025

Figure 5–9: Global Vaccines Market for Meningococcal Disease (Million US$),2015 – 2018

Figure 5–10: Global Vaccines Market for Meningococcal Disease Forecast (Million US$),2019 – 2025

Figure 5–11: Global Vaccines Market for Hepatitis Disease (Million US$),2015 – 2018

Figure 5–12: Global Vaccines Market for Hepatitis Disease Forecast (Million US$),2019 – 2025

Figure 5–13: Global Vaccines Market for MMR Disease (Million US$),2015 – 2018

Figure 5–14: Global Vaccines Market for MMR Disease Forecast (Million US$),2019 – 2025

Figure 5–15: Global Vaccines Market for Rotavirus Disease (Million US$),2015 – 2018

Figure 5–16: Global Vaccines Market for Rotavirus Disease Forecast (Million US$),2019 – 2025

Figure 5–17: Global Vaccines Market for Varicella Disease (Million US$),2015 – 2018

Figure 5–18: Global Vaccines Market for Varicella Disease Forecast (Million US$),2019 – 2025

Figure 5–19: Global Vaccines Market for Other Diseases (Million US$),2015 – 2018

Figure 5–20: Global Vaccines Market for Other Diseases Forecast (Million US$),2019 – 2025

Figure 6–1: Global Vaccines Market for Pediatric (Million US$),2015 – 2018

Figure 6–2: Global Vaccines Market for Pediatric Forecast (Million US$),2019 – 2025

Figure 6–3: Global Vaccines Market for Adult (Million US$),2015 – 2018

Figure 6–4: Global Vaccines Market for Adult Forecast (Million US$),2019 – 2025

Figure 7–1: GlobalPrevnar/Prevnar 13 Market Value (Million US$),2015–2018

Figure 7–2: Global Prevnar/Prevnar 13 Market Value Forecast (Million US$),2019 – 2025

Figure 7–3: GlobalGardasil/Gardasil 9 Market Value (Million US$),2015–2018

Figure 7–4: GlobalGardasil/Gardasil 9 Market Value Forecast (Million US$),2019–2025

Figure 7–5: Global Vaxigrip Market Value (Million US$),2015 – 2018

Figure 7–6: Global Vaxigrip Market Value Forecast (Million US$),2019 – 2025

Figure 7–7: Global Fluzone Market Value (Million US$),2015–2018

Figure 7–8: Global Fluzone Market Value Forecast (Million US$),2019–2025

Figure 7–9: Global Flublok Market Value & Forecast (Million US$),2018– 2025

Figure 7–10: Global Varivax Market Value (Million US$),2015–2018

Figure 7–11: Global Varivax Market Value Forecast (Million US$),2019–2025

Figure 7–12: Global Menactra Market Value (Million US$),2015–2018

Figure 7–13: Global Menactra Market Value Forecast (Million US$),2019–2025

Figure 7–14: Global Proquad Market Value (Million US$),2015–2018

Figure 7–15: Global Proquad Market Value Forecast (Million US$),2019–2025

Figure 7–16: Global Pneumovax 23 Market Value (Million US$),2015–2018

Figure 7–17: Global Pneumovax 23 Market Value Forecast (Million US$),2019–2025

Figure 7–18: Global Fluarix/FluLaval Market Value (Million US$),2015–2018

Figure 7–19: Global Fluarix/FluLaval Market Value Forecast (Million US$),2019–2025

Figure 7–20: Global Havrix/Twinrix/Engerix–B Market Value (Million US$),2015–2018

Figure 7–21: Global Havrix/Twinrix/Engerix–B Market Value Forecast (Million US$),2019–2025

Figure 7–22: Global Priorix, Priorix Tetra, Varilrix Market Value (Million US$),2015 – 2018

Figure 7–23: Global Priorix, Priorix Tetra, Varilrix Market Value Forecast (Million US$),2019 – 2025

Figure 7–24: Global M–M–R ll Market Value (Million US$),2015–2018

Figure 7–25: Global M–M–R ll Market Value Forecast (Million US$),2019–2025

Figure 7–26: Global Adacel Market Value (Million US$),2015–2017

Figure 7–27: Global Adacel Market Value Forecast (Million US$),2018–2025

Figure 7–28: Global Boostrix Market Value (Million US$),2015–2018

Figure 7–29: Global Boostrix Market Value Forecast (Million US$),2019–2025

Figure 7–30: Global Bexsero Market Value (Million US$),2015–2018

Figure 7–31: Global Bexsero Market Value Forecast (Million US$),2019–2025

Figure 7–32: Global Menveo Market Value (Million US$),2015–2018

Figure 7–33: Global Menveo Market Value Forecast (Million US$),2019–2025

Figure 7–34: Global Cervarix Market Value (Million US$),2015 – 2018

Figure 7–35: Global Cervarix Market Value Forecast (Million US$),2019 – 2025

Figure 7–36: Global Trumenba Market Value (Million US$),2016–2018

Figure 7–37: Global Trumenba Market Value Forecast (Million US$),2019–2025

Figure 7–38: Global Shingrix Market Value& Forecast (Million US$),2017–2018

Figure 7–39: Global Shingrix Market Value & Forecast (Million US$),2019 – 2025

Figure 7–40: Global Pentacel, Pentaxim, Imovax, Hexaxim Market Value (Million US$),2015–2018

Figure 7–41: Global Pentacel, Pentaxim, Imovax, Hexaxim Market Value Forecast (Million US$),2018 – 2025

Figure 7–42: Global Rotateq Market Value (Million US$),2015 – 2018

Figure 7–43: Global Rotateq Market Value Forecast (Million US$),2019 – 2025

Figure 7–44: Global Zostavax Market Value (Million US$),2015 – 2018

Figure 7–45: Global Zostavax Market Value Forecast (Million US$),2019 – 2025

Figure 7–46: Global Rotarix Market Value (Million US$),2015 – 2018

Figure 7–47: Global Rotarix Market Value Forecast (Million US$),2019 – 2025

Figure 7–48: Global Synflorix Market Value (Million US$),2015 – 2018

Figure 7–49: Global Synflorix Market Value Forecast (Million US$),2019 – 2025

Figure 7–50: Global Pediarix/Infanrix Market Value (Million US$),2015 – 2018

Figure 7–51: Global Pediarix/Infanrix Market Value Forecast (Million US$),2019 – 2025

Figure 7–52: Global Ticovac Market Value (Million US$),2015 – 2018

Figure 7–53: Global Ticovac Market Value Forecast (Million US$),2019 – 2025

Figure 7–54: Global Biken Ha Market Value (Million US$),2015 – 2018

Figure 7–55: Global Biken Ha Market Value Forecast (Million US$),2019– 2025

Figure 7–56: Global Tetrabik Market Value (Million US$),2015 – 2018

Figure 7–57: Global Tetrabik Market Value Forecast (Million US$),2019 – 2025

Figure 7–58: Global Mearubik Market Value (Million US$),2015 – 2018

Figure 7–59: Global Mearubik Market Value Forecast (Million US$),2019 – 2025

Figure 7–60: Global Varicella (MTP) Market Value (Million US$),2015 – 2018

Figure 7–61: Global Varicella (MTP) Market Value Forecast (Million US$),2019 – 2025

Figure 7–62: Global Jebik V Market Value (Million US$),2015 – 2018

Figure 7–63: Global Jebik V Market Value Forecast (Million US$),2019 – 2025

Figure 7–64: Global FluMist/Fluenz Market Value (Million US$),2015 – 2018

Figure 7–65: Global FluMist/Fluenz Market Value Forecast (Million US$),2019 – 2025

Figure 7–66: Global BioThrax Market Value (Million US$),2015 – 2018

Figure 7–67: Global BioThrax Market Value Forecast (Million US$),2019 – 2025

Figure 7–68: Global Dukoral Market Value (Million US$),2015 – 2018

Figure 7–69: Global Dukoral Market Value Forecast (Million US$),2019 – 2025

Figure 7–70: Global Ixiaro Market Value (Million US$),2015 – 2018

Figure 7–71: Global Ixiaro Market Value Forecast (Million US$),2019 – 2025

Figure 7–72: Global InLive Market Value (Million US$),2015 – 2018

Figure 7–73: Global InLive Market Value Forecast (Million US$),2019 – 2025

Figure 7–74: Global Healive Market Value (Million US$),2015 – 2018

Figure 7–75: Global Healive Market Value Forecast (Million US$),2019 – 2025

Figure 7–76: Global Bilive Market Value (Million US$),2015 – 2018

Figure 7–77: Global Bilive Market Value Forecast (Million US$),2019 – 2025

Figure 7–78: Global Anflu Market Value (Million US$),2015 – 2018

Figure 7–79: Global Anflu Market Value Forecast (Million US$),2019 – 2025

Figure 7–80: Global EasySix Market Value (Million US$),2015 – 2018

Figure 7–81: Global EasySix Market Value Forecast (Million US$),2019 – 2025

Figure 7–82: Global Imvamune Market Value (Million US$),2015 – 2018

Figure 7–83: Global Imvamune Market Value Forecast (Million US$),2019 – 2025

Figure 7–84: Global Other Vaccines Market Value (Million US$),2015 – 2018

Figure 7–85: Global Other Vaccines Market Value Forecast (Million US$),2019 – 2025

Figure 9–1: Sanofi Pasteur Vaccines Market Value Analysis (Million US$),2015 – 2018

Figure 9–2: Sanofi Pasteur Vaccines Market Value Analysis (Million US$),2019 – 2025

Figure 9–3: GSK Vaccines Market Value Analysis (Million US$),2015 – 2018

Figure 9–4: GSK Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025

Figure 9–5: Merck Vaccines Market Value Analysis (Million US$),2015 – 2018

Figure 9–6: Merck Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025

Figure 9–7: Pfizer Vaccines Market Value Analysis (Million US$),2015 – 2018

Figure 9–8: Pfizer Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025

Figure 9–9: AstraZeneca Vaccines Market Value Analysis (Million US$),2015 – 2018

Figure 9–10: AstraZeneca Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025

Figure 9–11: Mitsubishi Tanabe Pharma Vaccines Market Value Analysis (Million US$),2015 – 2018

Figure 9–12: Mitsubishi Tanabe Pharma Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025

Figure 9–13: Emergent Biosolutions Vaccines Market Value Analysis (Million US$),2015 – 2018

Figure 9–14: Emergent Biosolutions Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025

Figure 9–15: Astlellas Pharma Inc Vaccines Market Value Analysis (Million US$),2015 – 2018

Figure 9–16: Valneva Vaccines Market Value Analysis (Million US$),2015 – 2018

Figure 9–17: Valneva Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025

Figure 9–18: Seqirus Vaccines Market Value Analysis (Million US$),2016 – 2018

Figure 9–19: Seqirus Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025

Figure 9–20: Bavarian Nordic Vaccines Market Value Analysis (Million US$),2015 – 2018

Figure 9–21: Bavarian Nordic Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025

Figure 9–22: Sinovac Vaccines Market Value Analysis (Million US$),2015 – 2018

Figure 9–23: Sinovac Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025

Figure 9–24: Panacea Biotec Vaccines Market Value Analysis (Million US$),2015 – 2018

Figure 9–25: Panacea Biotec Vaccines Market Value Analysis Forecast (Million US$),2019 – 2025